M2-based influenza vaccines: recent advances and clinical potential
Introduction: Current influenza vaccines can prevent disease caused by influenza viruses but require annual administration and almost yearly reformulation. An attractive alternative approach would be to use a vaccine that provides broad and, ideally, lifelong protection against all influenza A and B...
Saved in:
Main Authors: | Annasaheb Kolpe (Author), Bert Schepens (Author), Walter Fiers (Author), Xavier Saelens (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
mRNA Encoding a Bispecific Single Domain Antibody Construct Protects against Influenza A Virus Infection in Mice
by: Lien Van Hoecke, et al.
Published: (2020) -
Recent Advancement in mRNA Vaccine Development and Applications
by: Nojoud Al Fayez, et al.
Published: (2023) -
Seasonal influenza vaccine performance and the potential benefits of mRNA vaccines
by: Colin A. Russell, et al.
Published: (2024) -
Evaluation of the protective potential of antibody and T cell responses elicited by a novel preventative vaccine towards respiratory syncytial virus small hydrophobic protein
by: Heather L. Torrey, et al.
Published: (2020) -
Recent Advances in the Clinical Value and Potential of Dexmedetomidine
by: Liu X, et al.
Published: (2021)